Evidence map›Paper›PMID 21860217›Full record

ArticleJournal of innate immunity2012

Importance of Toll-like receptor 9 in host defense against M1T1 group A Streptococcus infections.

Annelies S Zinkernagel, Petr Hruz, Satoshi Uchiyama, Maren von Köckritz-Blickwede, Reto A Schuepbach, Tomoko Hayashi, Dennis A Carson, Victor Nizet

Abstract read
In one paragraph

Article in Journal of innate immunity, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed.

  1. Interplay between group AMicrobiology and molecular biology reviews : MMBR · 2024
    Review
  2. Article
  3. Evaluation of IL-17D in Host Immunity to Group AJournal of immunology (Baltimore, Md. : 1950) · 2020
    Article
  4. Article
  5. Group AMicrobiology spectrum · 2019
    Article
  6. Lipoteichoic acid anchor triggers Mincle to drive protective immunity against invasive group AProceedings of the National Academy of Sciences of the United States of America · 2018
    Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Responses of innate immune cells to group A Streptococcus.Frontiers in cellular and infection microbiology · 2014
    Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Annelies S ZinkernagelDivision of Pharmacology and Drug Discovery, Department of Pediatrics, University of California, San Diego, Calif., USA. annelies.zinkernagel @ usz.ch
Petr Hruz
Satoshi Uchiyama
Maren von Köckritz-Blickwede
Reto A Schuepbach
Tomoko Hayashi
Dennis A Carson
Victor Nizet

Funding

Protection Against Inhalation Anthrax with Inactivated SporesU01AI077989 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI GUINEY, DONALD G. · 2008 to 2012
$5.0M
GAS Switch from Colonizing Bacterium to Invasive PathogenR01AI077780 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI NIZET, VICTOR · 2008 to 2019
$3.8M
Proteolysis and Skin AntimicrobialsR01AR052728 · NIAMS · VETERANS MEDICAL RESEARCH FDN/SAN DIEGO · PI GALLO, RICHARD L · 2006 to 2015
$3.3M
PROTEOGLYCANS WOUND REPAIR AND INFLAMMATIONR01AR045676 · NIAMS · VETERANS MEDICAL RESEARCH FDN/SAN DIEGO · PI GALLO, RICHARD L · 2001 to 2005
$1.2M
NIAID NIH HHS AI077989NIAID NIH HHS AI77780NIAMS NIH HHS R01 AR045676NIAMS NIH HHS R01 AR052728
6 · The paper itself

Abstract

Timely recognition and elimination of invasive group A Streptococcus (GAS) by innate immunity is crucial to control infection. The intracellular pattern recognition receptor Toll-like receptor 9 (TLR9) promotes macrophage hypoxia-inducible factor-1α levels, oxidative burst and nitric oxide production in response to GAS. TLR9 contributes to GAS clearance in vivo in both localized cutaneous and systemic infection models.

Indexed as

AnimalsBlotting, WesternHypoxia-Inducible Factor 1, alpha SubunitMacrophagesMiceMice, Inbred C57BLMice, KnockoutNitric OxideStreptococcal InfectionsStreptococcus pyogenesToll-Like Receptor 9Hif1a protein, mouseHypoxia-Inducible Factor 1, alpha SubunitNitric OxideToll-Like Receptor 9

Identifiers

PMID21860217
PMCPMC3388268

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.